| Osteoclastogenesis--current knowledge and future perspectives MP Yavropoulou, JG Yovos J Musculoskelet Neuronal Interact 8 (3), 204-16, 2008 | 352 | 2008 |
| The role of the Wnt signaling pathway in osteoblast commitment and differentiation MP Yavropoulou, JG Yovos HORMONES-ATHENS- 6 (4), 279, 2007 | 247 | 2007 |
| Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome K Kotsa, MP Yavropoulou, O Anastasiou, JG Yovos Fertility and sterility 92 (3), 1053-1058, 2009 | 198 | 2009 |
| The molecular basis of bone mechanotransduction MP Yavropoulou, JG Yovos Journal of musculoskeletal & neuronal interactions 16 (3), 221, 2016 | 130 | 2016 |
| Denosumab discontinuation and the rebound phenomenon: a narrative review AD Anastasilakis, P Makras, MP Yavropoulou, G Tabacco, AM Naciu, ... Journal of clinical medicine 10 (1), 152, 2021 | 108 | 2021 |
| Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fractures MP Yavropoulou, AD Anastasilakis, P Makras, DG Tsalikakis, ... European Journal of Endocrinology 176 (2), 169-176, 2017 | 95 | 2017 |
| In vitro application of Mn-ferrite nanoparticles as novel magnetic hyperthermia agents A Makridis, K Topouridou, M Tziomaki, D Sakellari, K Simeonidis, ... Journal of materials chemistry B 2 (47), 8390-8398, 2014 | 90 | 2014 |
| Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment AD Anastasilakis, MP Yavropoulou, P Makras, GT Sakellariou, ... European journal of endocrinology 176 (6), 677-683, 2017 | 81 | 2017 |
| The PRIMARA study: a prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice P Schwarz, JJ Body, J Cáp, LC Hofbauer, M Farouk, A Gessl, JM Kuhn, ... European Journal of Endocrinology 171 (6), 727-735, 2014 | 70 | 2014 |
| Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover MP Yavropoulou, AH van Lierop, NAT Hamdy, R Rizzoli, SE Papapoulos Bone 51 (1), 153-157, 2012 | 62 | 2012 |
| Bazedoxifene for the treatment of osteoporosis MP Yavropoulou, P Makras, AD Anastasilakis Expert Opinion on Pharmacotherapy 20 (10), 1201-1210, 2019 | 58 | 2019 |
| Cinin hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review MP Yavropoulou, K Kotsa, AG Psarrakou, A Papazisi, T Tranga, S Ventis, ... Hormones 9, 274-278, 2010 | 55 | 2010 |
| Changes of circulating microRNAs in response to treatment with teriparatide or denosumab in postmenopausal osteoporosis AD Anastasilakis, P Makras, M Pikilidou, S Tournis, K Makris, I Bisbinas, ... The Journal of Clinical Endocrinology & Metabolism 103 (3), 1206-1213, 2018 | 54 | 2018 |
| The role of microRNAs in arterial stiffness and arterial calcification. An update and review of the literature S Nanoudis, M Pikilidou, M Yavropoulou, P Zebekakis Frontiers in genetics 8, 209, 2017 | 50 | 2017 |
| Role of vanadium in cellular and molecular immunology: association with immune-related inflammation and pharmacotoxicology mechanisms O Tsave, S Petanidis, E Kioseoglou, MP Yavropoulou, JG Yovos, ... Oxidative medicine and cellular longevity 2016, 2016 | 49 | 2016 |
| The role of Notch signaling in bone development and disease MP Yavropoulou, JG Yovos Hormones 13 (1), 24-37, 2014 | 46 | 2014 |
| The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study C Pontikis, MP Yavropoulou, KA Toulis, K Kotsa, K Kazakos, A Papazisi, ... Journal of women's health 20 (6), 971-976, 2011 | 46 | 2011 |
| Combination and sequential treatment in women with postmenopausal osteoporosis AD Anastasilakis, SA Polyzos, MP Yavropoulou, P Makras Expert Opinion on Pharmacotherapy 21 (4), 477-490, 2020 | 44 | 2020 |
| The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis MP Yavropoulou, C Xygonakis, M Lolou, F Karadimou, JG Yovos Hormones 13 (4), 476-487, 2014 | 43 | 2014 |
| The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation P Makras, NM Appelman-Dijkstra, SE Papapoulos, S van Wissen, ... The Journal of Clinical Endocrinology & Metabolism 106 (10), e4155-e4162, 2021 | 41 | 2021 |
John G. YovosAUTHVerified email at med.auth.gr
